Message on Covid-19 from Microbiome Insights

With each new day, our team is learning more about the impact of the global COVID-19 pandemic and is working hard to adapt to the changes. We recognize what’s at stake and are taking all precautions to safeguard our employees, including following the recommended guidelines from the CDC, and the Provincial and Federal governments.

Based on the local situation at this time, our lab remains open and operational, supporting our clients. We have taken precautions, such as limiting lab access to only essential personnel, and having our bioinformatics, sales and support teams work remotely - where they are available to answer your questions, provide updates on studies, and support logistics.

This is clearly a very dynamic time, and we are aware that we may face the necessity of temporarily suspending operations based on the situation here in Vancouver. We will notify you in the event of any changes.

Our relationships with clients, vendors, advisors, and industry colleagues mean everything to us. Despite large gatherings and travel being restricted for the foreseeable future, we are committed to continuing our conversations and collaborations. If you have any questions or want to talk about a project, please reach out for a virtual conversation: book an online chat with us here.

For sample shipments, we recommend talking directly to shipping companies for updates and reaching out to our team with any specific concerns. At present, FedEx and UPS are operating normally in the U.S. and Canada. If you are shipping from other regions, we recommend that you check with your provider before shipping samples to us.


Now more than ever, we want to work together to overcome what may be the largest global crisis we will face in our lifetimes. Most importantly, we wish safety and good health to you, your families and your communities.


Thank you and stay well,

Malcolm Kendall



About Microbiome Insights

Microbiome Insights, Inc. is a global leader providing end-to-end microbiome sequencing and comprehensive bioinformatic analysis. The company is headquartered in Vancouver, Canada where samples from around the world are processed in its College of American Pathologist (CAP) accredited laboratory. Working with clients from pharma, biotech, nutrition, cosmetic and agriculture companies as well as with world leading academic and government research institutions, Microbiome Insights has supported over 925 microbiome studies from basic research to commercial R&D and clinical trials. The company's team of expert bioinformaticians and data scientists deliver industry leading insights including biomarker discovery, machine-learning based modelling and customized bioinformatics analysis.